Where does Melbourne Health rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Melbourne Health ranks #41,643 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Melbourne Health hold?

Melbourne Health holds 6 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Melbourne Health's Innovation Score?

Melbourne Health has an Innovation Score of 50.8 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Melbourne Health's patent grant rate increasing or decreasing?

Melbourne Health's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Melbourne Health's patents?

Melbourne Health's patents average 19.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Melbourne Health patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Melbourne Health

Q: What technology areas does Melbourne Health focus on?

Melbourne Health's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 6 patents. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Melbourne ranks #41,643 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 12 technology areas.

#41,643
of 49,997 US assignees by volume: Top 12%
by Innovation Score (50.8/100): 19.7
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R41643 · Foreign Corporation #41,643 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #41,643/49,997
PHOTO-FINISH Mega Slam Hoops
CPC-FOCUS A61P · 12 areas
INNOV-PAR 50.8/100
CLAIMS-RICH 19.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mega Slam Hoops, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Melbourne Health · this assignee

51
3D Lighting… · lowest

7

What this shows Melbourne's Innovation Score is 50.8/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Melbourne's grants concentrate

Melbourne Health is a focused PatentsView assignee: 12 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2015. By volume, Melbourne sits between Mega Slam Hoops, LLC and Memc Singapore Pte. Ltd..

Melbourne's three-year grant acceleration

Melbourne Health shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mega Slam Hoops

6
Megabass

6
Meijo Nano Carbon

6
Meishan Crrc Fast…

6
Melodea

6
Meltin MMI

6
Memc Materials S…

6
Memc Singapore Pte

6
Melbourne Health ◀

6

What this shows Melbourne holds 6 patents at rank #41,557, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Melbourne

By rank, the assignees closest to #41,557 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Melbourne's primary technology class.

Melbourne's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Melbourne Health patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2019	1	16.7%
2022	2	33.3%
2023	1	16.7%
2025partial year	1	16.7%

Which technologies does Melbourne Health patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C12G - WINE; Preparation THEREOF; Alcoholic Beverages ; Preparation OF Alcoholic Beverages NOT Provided FOR IN Subclasses C12c OR C12h 3

A01H - NEW Plants OR ; NON-TRANSGENIC; Processes FOR Obtaining THEM; Plant Reproduction BY Tissue Culture Techniques 3

C12H - Pasteurisation, Sterilisation, Preservation, Purification, Clarification OR Ageing OF Alcoholic BEVERAGES; Methods FOR Altering THE Alcohol Content OF Fermented Solutions OR Alcoholic Beverages 3

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 3

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

C12C - BEER; Preparation OF Beer BY Fermentation ; Preparation OF Malt FOR Making BEER; Preparation OF Hops FOR Making Beer 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07K - Peptides 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#41,643

of 49,997 tracked assignees

Innovation Score

50.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Melbourne Health's patent record in context - here's where to go next.

Melbourne Health's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #41,643 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Melbourne Health against Mega Slam Hoops, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.